Skip to main content

Published locations for Beloranib reduces weight in Prader-Willi syndrome, but concerns remain

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Beloranib reduces weight in Prader-Willi syndrome, but concerns remain

User login

  • Reset your password
  • /content/beloranib-reduces-weight-prader-willi-syndrome-concerns-remain
  • /familypracticenews/article/108915/lipid-disorders/beloranib-reduces-weight-prader-willi-syndrome
  • /internalmedicinenews/article/108915/lipid-disorders/beloranib-reduces-weight-prader-willi-syndrome
  • /clinicalendocrinologynews/article/108915/lipid-disorders/beloranib-reduces-weight-prader-willi
  • /ecardiologynews/article/108915/lipid-disorders/beloranib-reduces-weight-prader-willi-syndrome
  • /cardiology/article/108915/lipid-disorders/beloranib-reduces-weight-prader-willi-syndrome-concerns
  • /endocrinology/article/108915/lipid-disorders/beloranib-reduces-weight-prader-willi-syndrome-concerns
  • /internalmedicine/article/108915/lipid-disorders/beloranib-reduces-weight-prader-willi-syndrome
  • /familymedicine/article/108915/lipid-disorders/beloranib-reduces-weight-prader-willi-syndrome